ImCheck Therapeutics

Production d'anticorps thérapeutiques

Adresse 31 chemin Joseph Aiguier 13402 Marseille

Site web

Téléphone 0413961490


Présentation de l'entreprise

“ImCheck Therapeutics is driving innovation in two powerful new areas of immune system modulation: the butyrophilins superfamily of immunomodulatory molecules and gamma-delta T cells. The company is developing next generation immunotherapeutics for patients with severe unmet medical needs with a primary focus on immuno-oncology. Our growing understanding of these novel targets has also identified unique opportunities in immune-mediated inflammatory disease also known as autoimmune diseases.” From